109134 ⎘
Structure or type of the nucleic acid; Type of nucleic acid; Antisense targeting other non-coding nucleic acids, e.g. antagomirs
METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER BY TARGETING ONCOGENIC TRANSFER RNAS
#2Compounds and Methods for Modulating UBE3A-ATS
#3EXOSOMES ISOLATED FROM MESENCHYMAL STEM CELLS AND USES THEREOF
#4ANTAGONISTS OF HUMAN MICRO RNA MIR-100, MIR-20, MIR-222, MIR-181 AND MIR-92 AND USES OF SAME
#5METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE
#6Synthetic Nanostructures Including Nucleic Acids and/or Other Entities
#7COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION
#8COMPOSITIONS AND METHODS TO TREAT NEUROLOGICAL DISEASES
#9MODIFIED ANTISENSE OLIGONUCLEOTIDES TARGETING FOXG1
#10CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE
#11ARTIFICIAL NUCLEIC ACID FOR INDUCING SPECIFIC THREE-DIMENSIONAL STRUCTURE
#12THROMBOMODULIN PROTEIN AND MIRNA FOR PREVENTING OR TREATING OSTEOATHRITIS
#13USE OF INTERFERING RNAS DIRECTED AGAINST THE CHOLINERGIC SYSTEM FOR CONTROLLING INSECT PESTS
#14Conjugated Antisense Compounds and Their Use
#15METHOD FOR TESTING PULMONARY HYPERTENSION, PATHOLOGICAL ANIMAL MODEL FOR PULMONARY ARTERIAL HYPERTENSION, AND PREVENTIVE OR THERAPEUTIC AGENT FOR PULMONARY HYPERTENSION
#16MODULATION OF ABCB11 GENE TRANSCRIPTION USING ANTISENSE OLIGONUCLEOTIDES TARGETING REGULATORY RNAS
#17REGULATION OF ARTIFICIAL MIRNAS BY ENDOGENOUS TISSUE-SPECIFIC MIRNAS AND METHODS OF USING THE SAME
#18miRNA-BASED COMPOSITIONS AND METHODS OF USE THEREOF
#19COMPOSITIONS FOR THE SILENCING OF snoRNAS AND METHODS OF USING SAME
#20METHODS FOR MODULATING HUMAN L1 RETROTRANSPOSONS RNA AND COMPOSITIONS FOR USE THEREIN
#21MIRNA COMBINATION FOR THE PREVENTION AND TREATMENT OF CANCER
#22ISOLATED CIRCULAR RNA AND USE THEREOF IN PREVENTING AND TREATING LUNG CANCER
#23Compositions for Treatment of Polycystic Kidney Disease
#24Compounds and Methods for Modulating UBE3A-ATS
#25INHIBITORS OF MIR-221 FOR THE TREATMENT OF SOLID NEOPLASMS AND PERIPHERAL NEUROTOXICITY INDUCED BY ANTICANCER DRUGS AND OTHER NEUROLOGICAL DISEASES RELATED TO MIR-221
#26TARGETED INHIBITION OF REVERSE TRANSCRIPTION USING ANTISENSE OLIGOS
#27SIGNAL ACTIVATABLE NUCLEIC ACID COMPLEXES
#28REVERSIR TM COMPOUNDS
#29P-ETHOXY NUCLEIC ACIDS FOR LIPOSOMAL FORMULATION
#30MODULATION OF GENE TRANSCRIPTION USING ANTISENSE OLIGONUCLEOTIDES TARGETING REGULATORY RNAS
#31METHODS OF MODULATING PROGRANULIN EXPRESSION USING ANTISENSE OLIGONUCLEOTIDES TARGETING REGULATORY RNAS
#32PRODUCTION OF VIRAL VECTORS
#33Lipid Based Nanoparticles for Targeted Gene Delivery to the Brain
#34COMPOUNDS AND COMPOSITIONS INCLUDING PHOSPHOROTHIOATED OLIGODEOXYNUCLEOTIDE, AND METHODS OF USE THEREOF
#35CONSTRUCTS, VIRAL VECTORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING LONG NONCODING RNA ANRIL FOR TREATMENT OF DISEASE
#36LNCRNA TRANSCRIPTS IN MELANOMAGENESIS
#37Methods and Compositions for Treatment of Polycystic Kidney Disease
#38ACTIVE TARGETING MICRORNA OLIGONUCLEOTIDE THERAPEUTICS FOR THE TREATMENT OF CARDIO-METABOLIC DISEASES
#39COMPOSITION FOR PREVENTION OR TREATMENT OF LIVER CANCER, COMPRISING MODIFIED RT-LET7 AS ACTIVE INGREDIENT
#40COMPRESSIBLE SODIUM CAPRATE FORMULATIONS
#41miR-141-3p MODULATORS AND USES THEREOF
#42Composition and Methods for Modulating Nuclear Enriched Abundant Transcript 1 to Treat Cognitive Impairment
#43MODULATION OF MICRORNA-335-5P FOR THE TREATMENT OF SODIUM CHANNELOPATHIES
#44COMPOSITIONS AND METHODS FOR TREATING CANCERS
#45ANISAMIDE-CONTAINING LIPIDS AND COMPOSITIONS AND METHODS OF USE THEREOF
#46MICRORNA INHIBITOR THERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS
#47MODULATING THE CELLULAR STRESS RESPONSE
#48COMPOUNDS FOR INHIBITING AMANZI
#49LIPID NANOPARTICLE (LNP) COMPOSITIONS FOR BRAIN-SELECTIVE CARGO DELIVERY, AND METHODS OF USE THEREOF
#50ANGELMAN SYNDROME ANTISENSE TREATMENT
#51THERAPEUTIC OLIGONUCLEOTIDES
#52COMPOSITIONS AND METHODS OF MODULATING LONG NONCODING TRANSCRIPTS ASSOCIATED WITH ARDS INDUCED PULMONARY FIBROSIS
#53ANTISENSE OLIGONUCLEOTIDE FOR USE IN THE TREATMENT OF PSORIASIS-INDUCED ITCHING AND PHOSPHOLIPID VESICLE COMPRISING SAID OLIGONUCLEOTIDE
#54ANTICANCER COMPOSITIONS AND METHODS FOR MAKING AND USING THEM
#55OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF MAKING THE SAME
#56NUCLEIC ACID AGENTS FOR TREATMENT OF NON-SMALL-CELL LUNG CANCER
#57COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES CONTAINING A miRNA INHIBITOR AND USE THEREOF
#58Methods for Treating Glioblastoma by Targeting Oncomirs
#59METHODS OF MODULATING RNA TRANSLATION
#60COMBINATION OF OLIGONUCLEOTIDES FOR MODULATING RTEL1 AND FUBP1
#61Nucleic Acid Sponges
#62COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION
#63NUCLEOTIDE AND USE THEREOF
#64METHOD FOR TREATING A DISEASE
#65Conditional Double Stranded Antisense Oligonucleotides
#66CHIMERIC COMPLEX AND THERAPEUTIC USES THEREOF
#67ANTISENSE INHIBITORS OF MIR17HG PRE-RNA AS THERAPEUTIC AGENTS IN CANCER
#68Compositions and methods for modulating apolipoprotein (a) expression
#69Modulation of gene transcription using antisense oligonucleotides targeting regulatory RNAs
#70METHODS FOR REACTIVATING GENES ON THE INACTIVE X CHROMOSOME
#71VON WILLEBRAND FACTOR (VWF)-TARGETING AGENTS AND METHODS OF USING THE SAME
#72REDUCING INTRON RETENTION
#73METHODS FOR ENHANCING UTROPHIN PRODUCTION VIA INHIBITION OF MICRORNA
#74MICRORNA-134 INHIBITORS
#75OLIGONUCLEOTIDE CONJUGATES TARGETED TO THE TRANSFERRIN RECEPTOR
#76Methods and Compositions for Treatment of Polycystic Kidney Disease
#77AGENTS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF HYPOXIA AND ISCHEMIA-RELATED DISORDERS
#78USE OF MIRNA-485 INHIBITORS FOR TREATING DISEASES OR DISORDERS ASSOCIATED WITH ABNORMAL NLRP3 EXPRESSION
#79GLP-1 RECEPTOR LIGAND MOIETY CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF
#80COMPOSITIONS AND METHODS OF USE FOR MUTATED HOTAIR IN THE TREATMENT OF CANCERS
#81PEPTIDE NUCLEIC ACIDS FOR SPATIOTEMPORAL CONTROL OF CRISPR-CAS BINDING
#82Conjugated antisense compounds and their use
#83Methods and Compositions for Managing Vascular Conditions Using miR-483 Mimics and HIF1alpha Pathway Inhibitors
#84CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE
#85MODIFIED NUCLEIC ACIDS, HYBRID GUIDE RNAS, AND USES THEREOF
#86TREATING CANCER
#87MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes
#88TMEM173 saRNA Compositions and Methods of Use
#89Methods for Treatment of Alport Syndrome
#90Noninvasive AAV Vectors For Highly Efficient Gene Delivery To The Nervous System
#91OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF MAKING THE SAME
#92METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE
#93C/EBP Alpha Short Activating RNA Compositions and Methods of Use
#94GENETICALLY MODIFIED CELLS AND USES THEREOF FOR PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE
#95METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION
#96ANTISENSE OLIGONUCLEOTIDES INCREASING FOXG1 EXPRESSION
#97ENGINEERED NUCLEIC ACIDS TARGETING LONG NONCODING RNA INVOLVED IN PATHOGENIC INFECTION
#98COMPOSITIONS AND METHODS FOR TREATMENT OF CARDIAC DISEASES
#99Albumin Production and Cell Proliferation
#100DNA DAMAGE DEPENDENT MICRORNA SIGNATURE FOR CANCERS, METHODS AND USES RELATED THERETO
#101Anticancer compositions and methods for making and using them
#102TARGETING XIST AND RNA METHYLATION FOR X REACTIVATION THERAPY
#103USE OF LONG NON-CODING RNAS IN MEDULLOBLASTOMA
#104METHODS TO RE-ENGAGE A FETAL WOUND HEALING PATHWAY FOR ADULT SKIN REPAIR
#105RNA Interactome of Polycomb Repressive Complex 1 (PRC1)
#106Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereof
#107USES FOR PREVENTION OR TREATMENT OF BRAIN DISEASES USING MICRORNA
#108Angelman syndrome antisense treatment
#109TREATMENT AND DETECTION OF LIVER FIBROSIS AND LIVER DISEASE USING MICRORNA
#110THROMBUS IMAGING APTAMERS AND METHODS OF USING SAME
#111Targeting enhancer RNAs for the treatment of primary brain tumors
#112COMPOSITIONS AND METHOD FOR TREATING THALASSEMIA
#113PREPARATION METHOD FOR DIABETES EARLY WARNING AND/OR DIAGNOSTIC REAGENT KIT BASED ON HSA-MIR-320A, MEDICAMENT FOR PREVENTING DIABETES, SCREENING METHOD FOR MEDICAMENT, AND PREPARATION METHOD THEREFOR
#114MAGNETIC INORGANIC IRON-BASED NANOPARTICLES
#115Treatment of Airway Conditions by Modulation of MiR200 Family MicroRNAs
#116MOTOR NEURON-SPECIFIC EXPRESSION VECTORS
#1173'-UTR SEQUENCES FOR STABILIZATION OF RNA
#118CIRCULAR miRNA SPONGES
#119MIR-96-5P INHIBITOR AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
#120SMALL INTERFERING DEOXYRIBONUCLEIC ACID (SIDNA) AGAINST METALLO-BETA LACTAMASE GENE
#121MicroRNA-TARGETED THERAPY FOR CARDIAC REPAIR
#122Reducing intron retention
#123COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION
#124COMPOSITIONS AND METHODS FOR INCREASING SODIUM CURRENT IN CARDIAC CELLS
#125PEPTIDE NUCLEIC ACID CONJUGATES
#126MICRORNAS FOR THE PREVENTION OF CLINICAL VENOUS THROMBOEMBOLIC DISEASE
#127DIAGNOSTIC METHODS USING PCG-1A EXPRESSION
#128METHOD OF DELIVERING NUCLEIC ACID TO IMMUNE CELLS USING RBCEV
#129DIAGNOSTIC METHODS USING SIRT1 EXPRESSION
#130ONCOLYTIC VIRAL VECTORS AND USES THEREOF
#131Angleman syndrome antisense treatment
#132Compositions for treatment of polycystic kidney disease
#133MESENCHYMAL STROMAL CELLS AND EXTRACELLULAR VESICLES FOR TREATING VIRAL INFECTIONS, INFLAMMATION, AND TISSUE FIBROSIS
#134Increasing gene expression
#135Compositions comprising reversibly modified oligonucleotides and uses thereof
#136COMPOSITIONS COMPRISING MODIFIED CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF
#137Pan-Genotypic Agents Against Influenza Virus and Methods of Using the Same
#138NOVEL PRECURSOR MIRNA AND APPLICATION THEREOF IN TUMOR TREATMENT
#139ANTISENSE OLIGONUCLEOTIDES FOR TREATMENT OF CANCER STEM CELLS
#140REGULATION OF VON WILLEBRAND FACTOR (VWF)
#141MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes
#142Modulation of huntingtin expression
#143Methods for reactivating genes on the inactive X chromosome
#144COMPOUNDS AND METHODS FOR MODULATING C90RF72
#145Compounds and methods for modulating UBE3A-ATS
#146MODULATING GENOMIC COMPLEXES
#147RNA Interactome of Polycomb Repressive Complex 1 (PRC1)
#148REFILLABLE DRUG DELIVERY DEVICES AND METHODS OF USE THEREOF
#149LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY
#150MATERIALS AND METHODS FOR MODIFYING THE ACTIVITY OF T CELLS
#151Long Noncoding RNA Implicated in Cardiovascular Disease and Use Thereof
#152LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY
#153COMPOSITIONS AND METHODS FOR MITIGATION OF ISCHEMIC REPERFUSION INJURY
#154Oligonucleotide compositions and methods of making the same
#155COMPOSITIONS AND METHODS FOR RNA INTERFERENCE
#156TRANS-CYCLOOCTENE LABELED ANTISENSE OLIGONUCLEOTIDES, RADIO LABELED TETRAZINE AND METHODS
#157METHODS OF INDUCING INSULIN PRODUCTION
#158COMPOSITIONS AND METHODS FOR DETECTING AND TREATING INSULIN RESISTANCE
#159LONG NON-CODING RNA IN CANCER
#160COMPOSITIONS AND METHODS FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA
#161COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION
#162COMPOSITIONS AND METHODS FOR DECREASING INTRAOCULAR PRESSURE
#163MEDICAL USES, METHODS AND USES
#164Inhibitors of microRNA 451a for Treatment of Endometriosis
#165REVERSIR™ compounds
#166REDUCTION OF BONE RESORPTION, ESPECIALLY IN CHRONIC JOINT DISEASES
#167TREATMENT OF HEART FAILURE IN HUMAN SUBJECTS
#168MEDIATORS OF GENE SILENCING
#169VIRAL VECTORS AND NUCLEIC ACIDS FOR USE IN THE TREATMENT OF PF-ILD AND IPF
#170METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE
#171Therapeutic Targeting of a microRNA to Treat Duchenne Muscular Dystrophy
#172Compositions and Methods for Inhibiting Cancers and Viruses
#173TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF
#174OLIGONUCLEOTIDES AND METHODS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION
#175MODIFYING THE SPECIFICITY OF NON-CODING RNA MOLECULES FOR SILENCING GENES IN EUKARYOTIC CELLS
#176HYBRID NUCLEIC ACID SWITCHES
#177INHIBITOR OF MIR-129 AND USES THEREOF
#178HETERO DOUBLE-STRANDED antimiR
#179MODULATION OF MICRORNAS AGAINST MYOTONIC DYSTROPHY TYPE 1 AND ANTAGONISTS OF MICRORNAS THEREFOR
#180TARGETING MICRORNAS TO OVERCOME DRUG TOLERANCE AND RESISTANCE
#181Methods of modulating RNA translation
#182REVERSIR TM COMPOUNDS
#183Polycomb-associated Non-Coding RNAs
#184METHODS FOR CONTROLLING SEIZURES BY MANIPULATING THE LEVELS OF MICRORNA-211 (miR-211) IN THE BRAIN
#185MicroRNA Compounds and Methods for Modulating MIR-21 Activity
#186Methods for Treatment of Alport Syndrome
#187Methods for Oral Delivery of Oligonucleotides
#188Methods and compositions for managing vascular conditions using miR-483 mimics and HIF1alpha pathway inhibitors
#189Angelman syndrome antisense treatment
#190STABILIZED THROMBIN
#191USE OF MIR-204 INHIBITOR TO INCREASE NURR1 PROTEIN EXPRESSION
#192Compounds and Methods for Use in Dystrophin Transcript
#193METABOLIC BENEFITS OF SHORT MIR-22 MIRNA ANTAGOMIR THERAPIES
#194Modulating the cellular stress response
#195RNA nanoparticles and method of use thereof
#196Compositions and methods for treatment of cardiac diseases
#197METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE
#198COMPOUND AND METHOD FOR TREATING MYOTONIC DYSTROPHY
#199COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION
#200Methods of Manipulating the Fate of Cells
#201Anti-angiogenic miRNA therapeutics for inhibiting corneal neovascularization
#202Self-replicating cell selective gene delivery compositions, methods, and uses thereof
#203P-ethoxy nucleic acids for liposomal formulation
#204CARGO LOADED EXTRACELLULAR VESICLES
#205Treatment for NEAT1 associated disease
#206Compounds and Methods for Modulation of Transcript Processing
#207MiRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation
#208COMPOUNDS OF CHEMICALLY MODIFIED OLIGONUCLEOTIDES AND METHODS OF USE THEREOF
#209COMPLEX CAPABLE OF INHIBITING GENETIC FUNCTION IN EXOSOME, AND CANCER PROLIFERATION AND/OR METASTASIS SUPPRESSOR
#210COMPOSITIONS COMPRISING INTERMEDIATE NON-CODING RNA REGULATORS MODULATING THE EXPRESSION OF ETV6 OR FOXO1 AND USES THEREOF
#211COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACUTE AND CHRONIC PRURITIS
#212Compounds and methods for modulating UBE3A-ATS
#213Compositions and methods of inhibiting gene expression in a lung
#214METHOD FOR DETERMINING DECREASE IN FUNCTIONS OF HIPPOCAMPUS BY USING CORRELATION BETWEEN MICRO RNA AND NMDA RECEPTOR, METHOD FOR INHIBITING DECREASE IN FUNCTIONS, AND METHOD FOR SCREENING FOR INHIBITORS OF DECREASE IN FUNCTIONS
#215COMBINATION THERAPIES COMPRISING C/EBP ALPHA SARNA
#216MICRORNA INHIBITORS FOR USE IN TREATING METABOLIC DISEASES
#217Targeted Self-Assembly of Functionalized Carbon Nanotubes on Tumors
#218Von Willebrand Factor (VWF)-targeting agents and methods of using the same
#219METHODS FOR REACTIVATING GENES ON THE INACTIVE X CHROMOSOME
#220Composition for preventing or treating neurodegenerative disease
#221C/EBP ALPHA SARNA COMPOSITIONS AND METHODS OF USE
#222MICRORNA TARGETING AGENT FOR TREATMENT OF HEART DISEASE
#223RNA-AIDED IMMUNOTHERAPEUTICS
#224Treatment of angiogenesis disorders
#225Modulation of Huntington expression
#226COMPOSITIONS AND METHODS
#227Inhibitors of metastasis
#228Uses for prevention or treatment of brain diseases using microRNA
#229Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereof
#230RNA nanoparticles for brain tumor treatment
#231MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes
#232COMPOSITIONS AND METHODS TO PROMOTE THYMIC REGENERATION
#233MicroRNA Compounds and Methods for Modulating MIR-122
#234FUNCTIONAL TARGETS OF MIR-6891-5P & APPLICATIONS THEREOF
#235Modified Oligonucleotides for Treatment of Polycystic Kidney Disease
#236Therapeutic oligonucleotides
#237Compositions and methods for modulating apolipoprotein (a) expression
#238Methods and compositions for treating inflammatory diseases
#239Means and methods to treat inflammatory diseases
#240Inhibition of mir-22 miRNA by APT-110
#241PHARMACEUTICAL COMPOSITION
#242COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION
#243Inhibitors of micro-RNA 22
#244Micro-RNA and obesity
#245COMPOUNDS OF CHEMICALLY MODIFIED OLIGONUCLEOTIDES AND METHODS OF USE THEREOF
#246Conjugated antisense compounds and their use
#247METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE
#248AAV-based treatment of cholesterol-related disorders
#249Uses for prevention or treatment of brain diseases using microrna
#250Compositions and methods for treatment of cardiac diseases
#251C/EBP alpha saRNA compositions and methods of use
#252Angelman syndrome antisense treatment
#253Methods of inducing insulin production
#254Therapeutic targeting of a microRNA to treat Duchenne muscular dystrophy
#255Thrombus imaging aptamers and methods of using same
#256Motor neuron-specific expression vectors
#257MiRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation
#258Treatment of HER-2 dependent cancer using an agent that modulates the activity of a miRNA
#259Methods of polynucleotide preparation using multivalent cation salt compositions
#260CANCER BIOMARKERS AND METHODS OF USE
#261Method for determining decrease in functions of hippocampus by using correlation between micro RNA and NMDA receptor, method for inhibiting decrease in functions, and method for screening for inhibitors of decrease in functions
#262C/EBP ALPHA SHORT ACTIVATING RNA COMPOSITIONS AND METHODS OF USE
#263TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF
#264MicroRNA Compounds and Methods for Modulating MIR-21 Activity
#265Methods for treating chondrosarcoma using microrna(miR)
#266Preeclampsia
#267ALBUMIN PRODUCTION AND CELL PROLIFERATION
#268as a diagnostic and therapeutic target for NAFLD, NASH, metabolic syndrome, and hepatic fibrosis
#269Methods for Treatment of Alport Syndrome
#270MicroRNA inhibitor therapy in systemic lupus erythematosus
#271Recombinant EGFL7, EGFL7 antibodies, and uses thereof
#272Modulation of huntingtin expression
#273RNA-modulating agents
#274GLP-1 RECEPTOR LIGAND MOIETY CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF
#275Methods for identification and modification of lncRNA associated with target genotypes and phenotypes
#276Antisense oligonucleotides for treatment of cancer stem cells
#277Methods for treatment of polycystic kidney disease
#278Reducing intron retention
#279COMPOSITIONS AND METHODS FOR MODULATING HBV EXPRESSION
#280tRNA derived small RNAs (tsRNAs) involved in cell viability
#281Polycomb-Associated Non-Coding RNAs
#282REFILLABLE DRUG DELIVERY DEVICES AND METHODS OF USE THEREOF
#283Methods And Compositions For Controlling Cardiac Fibrosis And Remodeling
#284MICRO-RNA FAMILY THAT MODULATES FIBROSIS AND USES THEREOF
#285MICRO-RNAS THAT MODULATE LYMPHANGIOGENESIS AND INFLAMMATORY PATHWAYS IN LYMPHATIC VESSEL CELLS
#286Compositions and methods for detecting and treating insulin resistance
#287Modified Oligonucleotides for Treatment of Polycystic Kidney Disease
#288LncRNAs for therapy and diagnosis of cardiac hypertrophy
#289Oncolytic viral vectors and uses thereof
#290Long non-coding RNA in cancer
#291IncRNAs GADLOR 1 and 2 for use in treating and preventing cardiac remodelling
#292HETERO DOUBLE-STRANDED antimiR
#293P-ethoxy nucleic acids for liposomal formulation
#294Methods of reducing expression of x-inactivation escapee genes and autosomal genes
#295Gemcitabine Derivatives for Cancer Therapy
#296Methods for controlling seizures by manipulating the levels of microRNA-211 (miR-211) in the brain
#297Methods and compositions for managing vascular conditions
#298Peptide nucleic acid conjugates
#299A METHOD FOR REGULATING THE FUNCTION OF A HEART CELL, RELATED NUCLEOTIDES AND COMPOUNDS
#300MicroRNA inhibitor